These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35767669)

  • 1. Kratom use as more than a "self-treatment".
    Smith KE; Dunn KE; Rogers JM; Grundmann O; McCurdy CR; Garcia-Romeu A; Schriefer D; Swogger MT; Epstein DH
    Am J Drug Alcohol Abuse; 2022 Nov; 48(6):684-694. PubMed ID: 35767669
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-Prescribed Buprenorphine Use Mediates the Relationship between Heroin Use and Kratom Use among a Sample of Polysubstance Users.
    Smith KE; Bunting AM; Walker R; Hall MT; Grundmann O; Castillo O
    J Psychoactive Drugs; 2019; 51(4):311-322. PubMed ID: 30961450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the self-reported motivations of kratom (
    Grundmann O; Veltri CA; Morcos D; Knightes D; Smith KE; Singh D; Corazza O; Cinosi E; Martinotti G; Walsh Z; Swogger MT
    Am J Drug Alcohol Abuse; 2022 Jul; 48(4):433-444. PubMed ID: 35389321
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study.
    Schimmel J; Amioka E; Rockhill K; Haynes CM; Black JC; Dart RC; Iwanicki JL
    Addiction; 2021 Jan; 116(1):176-181. PubMed ID: 32285981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kratom's Emergence and Persistence Within the US Polydrug Epidemic.
    Smith KE; Rogers JM; Feldman JD
    Curr Addict Rep; 2023; 10(2):262-271. PubMed ID: 37266191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program.
    Smith KE; Lawson T
    Drug Alcohol Depend; 2017 Nov; 180():340-348. PubMed ID: 28950240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kratom use and mental health: A systematic review.
    Swogger MT; Walsh Z
    Drug Alcohol Depend; 2018 Feb; 183():134-140. PubMed ID: 29248691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kratom Use Among U.S. Adolescents: Analyses of the 2019 National Survey on Drug Use and Health.
    Sharma V; Cottler LB; Bares CB; Lopez-Quintero C
    J Adolesc Health; 2022 Apr; 70(4):677-681. PubMed ID: 34836801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users.
    Singh D; Yeou Chear NJ; Narayanan S; Leon F; Sharma A; McCurdy CR; Avery BA; Balasingam V
    J Ethnopharmacol; 2020 Mar; 249():112462. PubMed ID: 31816368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating health information provided to kratom consumers by good manufacturing practice-qualified vendors.
    Hill K; Gibson S; Grundmann O; Smith KE; Ballard J; Stanciu CN
    Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):21. PubMed ID: 37041624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic.
    Garcia-Romeu A; Cox DJ; Smith KE; Dunn KE; Griffiths RR
    Drug Alcohol Depend; 2020 Mar; 208():107849. PubMed ID: 32029298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of Lifetime Nonmedical Opioid, Methamphetamine, and Kratom Use within a Nationally Representative US Sample.
    Smith KE; Rogers JM; Strickland JC
    J Psychoactive Drugs; 2022; 54(5):429-439. PubMed ID: 34842079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and characteristics of self-reported kratom use in a representative US general population sample.
    Covvey JR; Vogel SM; Peckham AM; Evoy KE
    J Addict Dis; 2020; 38(4):506-513. PubMed ID: 32657217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ecological Momentary Assessment of Self-Reported Kratom Use, Effects, and Motivations Among US Adults.
    Smith KE; Panlilio LV; Feldman JD; Grundmann O; Dunn KE; McCurdy CR; Garcia-Romeu A; Epstein DH
    JAMA Netw Open; 2024 Jan; 7(1):e2353401. PubMed ID: 38277146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Renal Insufficiency Associated With Consumption of Hydrocodone- and Morphine-Adulterated Kratom (Mitragyna Speciosa).
    LeSaint KT; Yin S; Sharma A; Avery BA; McCurdy CR; Waksman JC
    J Emerg Med; 2022 Jul; 63(1):e28-e30. PubMed ID: 35940982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kratom as a substitute for opioids: Results from an online survey.
    Coe MA; Pillitteri JL; Sembower MA; Gerlach KK; Henningfield JE
    Drug Alcohol Depend; 2019 Sep; 202():24-32. PubMed ID: 31284119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public Perceptions toward Kratom (
    Singh D; Narayanan S; Suraya S; Saref A; Grundmann O; Prozialeck WC; Corazza O; Swogger MT; Griffin O; Balasingam V
    J Psychoactive Drugs; 2020; 52(3):282-288. PubMed ID: 32153252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kratom as an opioid alternative: harm, or harm reduction? A systematic review of literature.
    Stanciu C; Ahmed S; Gnanasegaram S; Gibson S; Penders T; Grundmann O; McCurdy C
    Am J Drug Alcohol Abuse; 2022 Sep; 48(5):509-528. PubMed ID: 36001875
    [No Abstract]   [Full Text] [Related]  

  • 19. Polysubstance use profiles among US adults using Kratom (Mitragyna speciosa): A latent class analysis using The National Survey on Drug Use and Health (NSDUH).
    Falise AM; Hoeflich CC; Nutley SK; Lopez-Quintero C; Striley CW
    Am J Addict; 2023 Jan; 32(1):76-80. PubMed ID: 36222599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social, psychological, and substance use characteristics of U.S. adults who use kratom: Initial findings from an online, crowdsourced study.
    Smith KE; Dunn KE; Grundmann O; Garcia-Romeu A; Rogers JM; Swogger MT; Epstein DH
    Exp Clin Psychopharmacol; 2022 Dec; 30(6):983-996. PubMed ID: 34735202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.